Literature DB >> 23069480

Livin expression may be regulated by miR-198 in human prostate cancer cell lines.

Lin Ye1, Sheng Li, Dingwei Ye, Deyong Yang, Feng Yue, Yanjie Guo, Xiaochi Chen, Feng Chen, Jianing Zhang, Xishuang Song.   

Abstract

Livin has been recently described as an inhibitor of apoptosis, which is established to be associated with a variety of cancers. Metastatic prostate cancer cell line DU145 expresses high level of Livin mRNA yet low level of its protein. Thus, we hypothesised that Livin was regulated by some miRNAs in prostate cancer cells. Livin mRNA and protein expression were investigated by reverse-transcriptase polymerase chain reaction (RT-PCR) and Western blot, respectively. Hairpin RT-PCR was performed to analyse suspected miRNAs. Livin 3'-untranslated region (3'-UTR) wild type and mutant dual-luciferase reporter vectors were constructed. The miRNAs targeting Livin were predicted by the online software - TargetScan and miRBase, and then validated by dual luciferase reporter gene assay. We found that post-transcriptional inhibition of Livin occurred in DU145 cells, assumedly due to the miRNA pathway. Among 6 candidate miRNAs, miR-198 expression was identified to be negatively correlated with Livin expression level in some prostate cancer cell lines. Further study revealed miR-198-mediated repression of Livin expression. Therefore, the regulation of Livin expression may involve miR-198 in prostate cancer cell lines. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23069480     DOI: 10.1016/j.ejca.2012.08.029

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

1.  Screening biomarkers of prostate cancer by integrating microRNA and mRNA microarrays.

Authors:  Jiayu Feng; Chibing Huang; Xinwei Diao; Minqi Fan; Pingxian Wang; Ya Xiao; Xiao Zhong; Ronghua Wu
Journal:  Genet Test Mol Biomarkers       Date:  2013-08-28

2.  The promising role and prognostic value of miR-198 in human diseases.

Authors:  Xiaoping Wang; Yanxia Zhu; Qiuli Xie
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

3.  MicroRNA‑198 suppresses tumour growth and metastasis in oral squamous cell carcinoma by targeting CDK4.

Authors:  Yuanyuan Kang; Ying Zhang; Yan Sun
Journal:  Int J Oncol       Date:  2021-05-13       Impact factor: 5.650

4.  Decreased miR-198 expression and its prognostic significance in human gastric cancer.

Authors:  Zhigang Cui; Xin Zheng; Di Kong
Journal:  World J Surg Oncol       Date:  2016-02-06       Impact factor: 2.754

5.  Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.

Authors:  Yue-Ya Liang; Jia-Cheng Huang; Rui-Xue Tang; Wen-Jie Chen; Peng Chen; Wei-Luan Cen; Ke Shi; Li Gao; Xiang Gao; An-Gui Liu; Xiao-Tong Peng; Gang Chen; Su-Ning Huang; Ye-Ying Fang; Yong-Yao Gu
Journal:  World J Surg Oncol       Date:  2018-02-02       Impact factor: 2.754

6.  miR-198 targets SHMT1 to inhibit cell proliferation and enhance cell apoptosis in lung adenocarcinoma.

Authors:  Shujun Wu; Guojun Zhang; Ping Li; Shanshan Chen; Furui Zhang; Juan Li; Chenyang Jiang; Xiaonan Chen; Yuanyuan Wang; Yuwen Du; Qianqian Sun; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2015-11-09

7.  miR-198 Represses the Proliferation of HaCaT Cells by Targeting Cyclin D2.

Authors:  Jian Wang; Guorong Dan; Tao Shangguan; Han Hao; Ran Tang; Kaige Peng; Jiqing Zhao; Huiqin Sun; Zhongmin Zou
Journal:  Int J Mol Sci       Date:  2015-07-27       Impact factor: 5.923

8.  Expression and clinical significance of livin protein in hepatocellular carcinoma.

Authors:  Hua Guo; Ying-tang Gao; Qin Zhang; Li Jing; Tong Liu; Wen-xia Shi; Dao-kuan Zhai; Xiang Jing; Zhi Du
Journal:  Dis Markers       Date:  2013-10-03       Impact factor: 3.434

9.  MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.

Authors:  Lin Wang; Guanhua Song; Weiwei Tan; Mei Qi; Lili Zhang; Jonathan Chan; Jindan Yu; Jinxiang Han; Bo Han
Journal:  Oncotarget       Date:  2015-11-03

10.  MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8.

Authors:  Minyu Wang; Jilin Wang; Xuan Kong; Huimin Chen; Yingchao Wang; Miao Qin; Yanwei Lin; Haoyan Chen; Jie Xu; Jie Hong; Ying-Xuan Chen; Weiping Zou; Jing-Yuan Fang
Journal:  Sci Rep       Date:  2014-09-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.